海森药业(001367.SZ)：前三季净利润8820.96万元 同比增长1.45%

Core Viewpoint - Haosen Pharmaceutical (001367.SZ) reported a year-on-year increase in revenue and net profit for the first three quarters of the year, indicating stable growth despite a slight decline in net profit after excluding non-recurring items [1] Financial Performance - The company's operating revenue for the first three quarters reached 359 million yuan, representing a year-on-year growth of 12.13% [1] - The net profit attributable to shareholders of the listed company was approximately 88.21 million yuan, showing a year-on-year increase of 1.45% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was about 84.76 million yuan, reflecting a year-on-year decline of 1.56% [1]